1721 |
Introduction to a New TAVI Valve - ACURATE neo2 |
Cheol Woong Yu |
Apr. 20. 23 |
1720 |
FFR Pullback Quantification to Guide Intervention: The Ongoing PPG Global Registry |
Nils Johnson |
Apr. 20. 23 |
1719 |
CT Guided PCI: A Novel Approach for Imaging Guided Interventions |
Carlos Collet |
Apr. 20. 23 |
1718 |
Precision Approaches for Acute Coronary Syndrome Based on OCT-determined Pathogenesis |
Yoshiyasu Minami |
Apr. 20. 23 |
1717 |
Role of Angio-based FFR for the Planning of PCI |
Hitoshi Matsuo |
Apr. 20. 23 |
1716 |
Prediction of Stent Expansion by IVUS and OCT |
Akiko Maehara |
Apr. 20. 23 |
1715 |
Synergetic Approach for Discordant Lesions Between FFR and Hyperemia Free Indexes |
Jung-Min Ahn |
Apr. 20. 23 |
1714 |
TAVR in Korea - Data from National TAVR Database |
Junghoon Lee |
Apr. 20. 23 |
1713 |
TAVR in Hong Kong - Sapien 3, Acurate Neo and Evolut PRO |
Cheung Chi Simon Lam |
Apr. 20. 23 |
1712 |
Valve in Valve TAVR in Stentless Bioprosthesis Surgical Valves |
Wojciech Wojakowski |
Apr. 20. 23 |